BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26727971)

  • 21. Delayed Diagnosis of a Nasal Type Lymphoma Misdiagnosed as Persistent Sinusitis.
    Celentano A; Mascolo M; Cirillo N; De Rosa G; Mignogna MD
    J Adolesc Young Adult Oncol; 2017 Jun; 6(2):381-384. PubMed ID: 28061034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis of brainstem involvement in NK/T cell lymphoma.
    So JC; Chan KH; Pang AW; Chan JK; Kwong YL
    Ann Hematol; 2014 Aug; 93(8):1433-4. PubMed ID: 24292537
    [No Abstract]   [Full Text] [Related]  

  • 23. [Extranodal NK/T cell lymphoma, nasal type with local recurrence in the contralateral nasal cavity 15 years after initial sequential chemoradiotherapy].
    Fujii T; Ohno N; Kitahara S; Kobayashi S; Sahara N; Sakamoto N; Arahira S; Matsunaga T
    Rinsho Ketsueki; 2022; 63(3):229-232. PubMed ID: 35387938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone.
    Kim BS; Kim DW; Im SA; Kim CW; Kim TY; Yoon SS; Heo DS; Bang YJ; Park S; Kim BK; Kim NK
    Ann Oncol; 2009 Jan; 20(1):121-8. PubMed ID: 18684695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nasal Type Extranodal Natural Killer/T (NK/T) Cell Lymphoma Presenting as Periorbital Cellulitis: A Case Report.
    Al Shawabkeh MA; Al Sulaiti M; Al Sa'ey H; Ganesan S
    Am J Case Rep; 2016 Dec; 17():934-938. PubMed ID: 27932776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rare case of low-grade extranodal NK/T-cell lymphoma, nasal type, arising in the setting of chronic rhinosinusitis and harboring a novel N-terminal KIT mutation.
    Devins K; Schuster SJ; Caponetti GC; Bogusz AM
    Diagn Pathol; 2018 Nov; 13(1):92. PubMed ID: 30470245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) plus L-asparaginase as a first-line therapy improves outcomes in stage III/IV NK/T cell-lymphoma, nasal type (NTCL).
    Kim M; Kim TM; Kim KH; Keam B; Lee SH; Kim DW; Lee JS; Jeon YK; Kim CW; Heo DS
    Ann Hematol; 2015 Mar; 94(3):437-44. PubMed ID: 25300500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concurrent chemoradiotherapy followed by L-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study.
    Kim SJ; Yang DH; Kim JS; Kwak JY; Eom HS; Hong DS; Won JH; Lee JH; Yoon DH; Cho J; Nam TK; Lee SW; Ahn YC; Suh C; Kim WS
    Ann Hematol; 2014 Nov; 93(11):1895-901. PubMed ID: 24947798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel JAK3-Activating Mutations in Extranodal NK/T-Cell Lymphoma, Nasal Type.
    Sim SH; Kim S; Kim TM; Jeon YK; Nam SJ; Ahn YO; Keam B; Park HH; Kim DW; Kim CW; Heo DS
    Am J Pathol; 2017 May; 187(5):980-986. PubMed ID: 28284718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extranodal NK/T-cell lymphoma: Updates in biology and management strategies.
    Yamaguchi M; Oguchi M; Suzuki R
    Best Pract Res Clin Haematol; 2018 Sep; 31(3):315-321. PubMed ID: 30213402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of secondary NK/T-cell lymphoma of the testis.
    Kobayashi T; Hangaishi A; Yamamoto G; Shinohara A; Morikawa T; Takazawa Y; Ota S; Imai Y; Nakamura F; Kurokawa M
    Ann Hematol; 2013 Jul; 92(7):997-8. PubMed ID: 23271214
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of localized nasal NK/T-cell lymphoma].
    Yamaguchi M
    Rinsho Ketsueki; 2008 Aug; 49(8):553-8. PubMed ID: 18800601
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy of pegaspargase, etoposide, methotrexate and dexamethasone in newly diagnosed advanced-stage extra-nodal natural killer/T-cell lymphoma with the analysis of the prognosis of whole blood EBV-DNA.
    Liang JH; Wang L; Peter Gale R; Wu W; Xia Y; Fan L; Li JY; Xu W
    Blood Cancer J; 2017 Sep; 7(9):e608. PubMed ID: 29016569
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy of pegaspargase in extra nodal natural killer/T-cell lymphoma nasal type: A case report from China.
    Xiong X; Cai Z; Yang J; Shu X
    J Cancer Res Ther; 2015; 11(3):665. PubMed ID: 26458696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Primary colonic extranasal NK/T-cell lymphoma: about a case].
    Fares S; Lamchahab M; Aniba M; Lembarki G; Mousalli N; Regragui M; Karkouri M; Quessar A
    Pan Afr Med J; 2017; 26():112. PubMed ID: 28533835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.
    Kim SJ; Kim K; Kim BS; Kim CY; Suh C; Huh J; Lee SW; Kim JS; Cho J; Lee GW; Kang KM; Eom HS; Pyo HR; Ahn YC; Ko YH; Kim WS
    J Clin Oncol; 2009 Dec; 27(35):6027-32. PubMed ID: 19884539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type.
    Ito Y; Kimura H; Maeda Y; Hashimoto C; Ishida F; Izutsu K; Fukushima N; Isobe Y; Takizawa J; Hasegawa Y; Kobayashi H; Okamura S; Kobayashi H; Yamaguchi M; Suzumiya J; Hyo R; Nakamura S; Kawa K; Oshimi K; Suzuki R
    Clin Cancer Res; 2012 Aug; 18(15):4183-90. PubMed ID: 22675173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NK/T Cell Lymphoma: Updates in Therapy.
    Suzuki R
    Curr Hematol Malig Rep; 2018 Feb; 13(1):7-12. PubMed ID: 29368155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose methotrexate, etoposide, dexamethasone and pegaspargase (MEDA) combination chemotherapy is effective for advanced and relapsed/refractory extranodal natural killer/T cell lymphoma: a retrospective study.
    Ding H; Chang J; Liu LG; Hu D; Zhang WH; Yan Y; Ma LY; Li ZC; Ma YJ; Hao SG; Tao R
    Int J Hematol; 2015 Aug; 102(2):181-7. PubMed ID: 25997870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved prognosis of extranodal NK/T cell lymphoma, nasal type of nasal origin but not extranasal origin.
    Yamaguchi M; Suzuki R; Miyazaki K; Amaki J; Takizawa J; Sekiguchi N; Kinoshita S; Tomita N; Wada H; Kobayashi Y; Niitsu N; Ando T; Maeda T; Saito B; Matsuoka H; Sakai R; Kubota N; Masaki Y; Kameoka Y; Asano N; Oguchi M; Katayama N
    Ann Hematol; 2019 Jul; 98(7):1647-1655. PubMed ID: 31001658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.